- Human Biospecimens
- Biospecimen Contributors
January 18, 2022
As the pandemic continues to rear its ugly head this winter, we have strengthened our fight against the disease by expanding our supplier network with the addition of a new reference lab in New York to support commercial and government customers focused on COVID-19 research involving the Omicron and Delta variants.
December 23, 2021
Researchers from Australia are exploring new ways to classify breast cancer subtypes in hopes of improving prognosis and treatment in the future.
December 2, 2021
Although many have suffered and died from COVID-19, the scientific community’s response to the disease has been in some ways a triumph, with effective vaccines developed in record-shattering time. We at iSpecimen were determined to join the effort to fight the disease early in the pandemic’s lifecycle. And we remain committed to the effort.
November 22, 2021
Twelve Americans reportedly die every day waiting for organ transplants that never come. But what if we could grow transplantable organs in livestock and harvest them to save human lives?
October 25, 2021
When hospitals first filled with COVID-19 patients in 2020 and much of the world began locking down, many patients postponed cancer screenings, causing health care leaders to worry. Some of the first evidence on the impact of those delayed screenings is trickling in, notably new colon cancer research out of France.
October 7, 2021
Lung cancer is a leading cause of cancer death, making up nearly 25% of all cancer deaths (not all of which are smoking-related), but only 5% to 6% of at-risk Americans undergo recommended CT screening, with many concerned about radiation exposure and invasive procedures.